immatics biotechnologies GmbH
Patents, Design & Utilities

Last updated:

List of all immatics biotechnologies GmbH patents 820 in total

Status Patent
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 3 Aug 2021
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 3 Aug 2021
Application
Utility: B*44 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS External link
Filling date: 8 Sep 2025 Issue date: 29 Jul 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 29 Jul 2021
Application
Utility: PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS External link
Filling date: 8 Sep 2025 Issue date: 29 Jul 2021
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers External link
Filling date: 8 Sep 2025 Issue date: 27 Jul 2021
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 27 Jul 2021
Grant
Utility: T cell receptors with improved pairing External link
Filling date: 8 Sep 2025 Issue date: 27 Jul 2021
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 20 Jul 2021
Grant
Utility: Peptides and T cells for use in immunother[[r]]apeutic treatment of various cancers External link
Filling date: 8 Sep 2025 Issue date: 20 Jul 2021
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 20 Jul 2021
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 20 Jul 2021
Application
Utility: PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Jul 2021
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Jul 2021
Grant
Utility: A*03 restricted peptides for use in immunotherapy against cancers and related methods External link
Filling date: 8 Sep 2025 Issue date: 13 Jul 2021
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 13 Jul 2021
Grant
Utility: Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers External link
Filling date: 8 Sep 2025 Issue date: 13 Jul 2021
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 13 Jul 2021
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 6 Jul 2021
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 6 Jul 2021
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 6 Jul 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 8 Sep 2025 Issue date: 24 Jun 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 8 Sep 2025 Issue date: 24 Jun 2021
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 22 Jun 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 8 Sep 2025 Issue date: 17 Jun 2021
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 15 Jun 2021
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 15 Jun 2021
Application
Utility: METHODS FOR IDENTIFYING RNA EDITING-DERIVED EPITOPES THAT ELICIT IMMUNE RESPONSES IN CANCER External link
Filling date: 8 Sep 2025 Issue date: 10 Jun 2021
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers External link
Filling date: 8 Sep 2025 Issue date: 8 Jun 2021
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 8 Jun 2021
Application
Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER External link
Filling date: 8 Sep 2025 Issue date: 3 Jun 2021
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LEUKEMIAS AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 3 Jun 2021
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 1 Jun 2021
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 1 Jun 2021
Grant
Utility: Peptides and combination thereof for use in the immunotherapy against cancers External link
Filling date: 8 Sep 2025 Issue date: 1 Jun 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NHL AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 27 May 2021
Grant
Utility: B*44 restricted peptides for use in immunotherapy against cancers and related methods External link
Filling date: 8 Sep 2025 Issue date: 25 May 2021
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 25 May 2021
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 25 May 2021
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 25 May 2021
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 20 May 2021
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 20 May 2021
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 20 May 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 20 May 2021
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 18 May 2021
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 18 May 2021
Grant
Utility: Peptides and combination thereof for use in the immunotherapy against cancers External link
Filling date: 8 Sep 2025 Issue date: 18 May 2021
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 13 May 2021
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 13 May 2021
Application
Utility: A*03 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS External link
Filling date: 8 Sep 2025 Issue date: 13 May 2021

Showing 250 to 300 of 820 patents.